Craig Hallum Issues Pessimistic Forecast for Aspen Aerogels (NYSE:ASPN) Stock Price

Aspen Aerogels (NYSE:ASPN - Free Report) had its price objective reduced by Craig Hallum from $21.00 to $18.00 in a research report released on Friday morning,Benzinga reports. They currently have a buy rating on the construction company's stock.

Several other research firms have also issued reports on ASPN. Piper Sandler lowered their target price on shares of Aspen Aerogels from $36.00 to $33.00 and set an "overweight" rating for the company in a report on Tuesday, October 22nd. Roth Mkm lowered their target price on shares of Aspen Aerogels from $36.00 to $31.00 and set a "buy" rating for the company in a report on Friday, November 8th. Canaccord Genuity Group lowered their target price on shares of Aspen Aerogels from $28.00 to $20.00 and set a "buy" rating for the company in a report on Thursday, January 16th. Seaport Res Ptn lowered shares of Aspen Aerogels from a "strong-buy" rating to a "hold" rating in a report on Wednesday, February 12th. Finally, Barclays lowered their target price on shares of Aspen Aerogels from $27.00 to $25.00 and set an "overweight" rating for the company in a report on Tuesday, November 12th. One research analyst has rated the stock with a sell rating, one has issued a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $24.67.

Aspen Aerogels Stock Down 1.0 %

Aspen Aerogels stock traded down $0.09 during trading hours on Friday, hitting $8.55. 2,796,169 shares of the stock traded hands, compared to its average volume of 2,151,431. The firm's 50-day moving average price is $12.06 and its two-hundred day moving average price is $18.36. The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27. The company has a market cap of $701.12 million, a PE ratio of 855.36 and a beta of 2.14. Aspen Aerogels has a one year low of $8.25 and a one year high of $33.15.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last posted its quarterly earnings data on Wednesday, February 12th. The construction company reported $0.15 earnings per share for the quarter, beating the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a return on equity of 5.06% and a net margin of 0.36%. On average, research analysts forecast that Aspen Aerogels will post 0.12 EPS for the current year.

Institutional Investors Weigh In On Aspen Aerogels

Hedge funds have recently added to or reduced their stakes in the stock. Sandia Investment Management LP purchased a new stake in Aspen Aerogels during the 4th quarter valued at $89,000. AlphaQuest LLC raised its stake in Aspen Aerogels by 54.0% during the 4th quarter. AlphaQuest LLC now owns 11,395 shares of the construction company's stock valued at $135,000 after buying an additional 3,998 shares during the last quarter. nVerses Capital LLC raised its stake in Aspen Aerogels by 45.0% during the 3rd quarter. nVerses Capital LLC now owns 5,800 shares of the construction company's stock valued at $161,000 after buying an additional 1,800 shares during the last quarter. KLP Kapitalforvaltning AS purchased a new stake in Aspen Aerogels during the 4th quarter valued at $164,000. Finally, Connors Investor Services Inc. purchased a new stake in Aspen Aerogels during the 4th quarter valued at $168,000. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.